EFPIA - NEWSLETTER

EFPIA Newsletter 03 December 2020

First COVID-19 vaccine approved

Commenting on the world’s first authorisation of a COVID-19 vaccine, Nathalie Moll said:

"Finding answers to health challenges is what drives us. It means never stopping asking questions, never giving up in the search for answers. And when a step forward happens, like yesterday's announcement of approval by the MHRA for the Pfizer BioNtech vaccine, it just drives us forward all the more. We know there is a long way to go, today is a good day and #WeWontRest in fighting this pandemic."

News

03 December 2020 ITN 2020 - We Won't Rest: Working together towards better patient outcomes

A new series of short films to showcase innovative partnerships that will change patient outcomes

02 December 2020 EFPIA statement on today's meeting of EU Health Ministers

In line with many of the views shared by Member States at today’s video conference of Health Ministers, EFPIA welcomes...

30 November 2020 EFPIA reaction to SPC evaluation publication

The evidence in the studies supporting the evaluation and the SWD confirm that the SPC Regulation works well.

Blogs

03 December 2020 Podcast: Is the pharmaceutical industry making too much money?

Welcome to 19 Conversations

03 December 2020 Embracing AI to improve patient care and advance innovation in pharma

EFPIA Position Paper on Artificial Intelligence

02 December 2020 The 10 key factors delaying patient access across Europe

Most patients in European countries have to wait much longer than needed to access new cancer medicines

01 December 2020 Moving towards the next normal

How changes driven by COVID-19 may shape pharma manufacturing in the long term

01 December 2020 Cancer – Acting Together Now

EU Cancer Plan delayed but the need for action remains

30 November 2020 To reimagine lung cancer care we must listen to and learn from patients

From drug development to clinical trials, it is so important that work to advance lung cancer care is firmly grounded...

30 November 2020 Unlocking the value of personalised cancer care

New LSE report tackles barriers to realising the full potential of personalised oncology

Events

08 DEC 2020

How to turn around the increasing burden of cardiovascular disease in Europe? Virtual event

Virtual event jointly organised by the European Heart Network and EFPIA

Learn more →

10 DEC 2020

Investing in innovation in health: A new industrial strategy for the COVID-19 era... Virtual event

We look forward to welcoming you online on 10 December.

Learn more →

What we are reading

Health budgets, patients pay the cost of fragmented diabetes care: report 24 November 2020 (Euractiv)

The Big Problems 01 December 2020 (Science Translational Medicine)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶